On-Demand Webinar

Sealing Pharma Commercialization Deals：为投资者创造最佳价值

It is crucial for biotech developers to engage in early commercial market assessment to generate…

Certara2021 年 3 月 5 日

Publication

BPS Article: 模型引导的药物再利用：新型病原体准备、反应和回顾的定量药理学方法

Abstract During a pandemic caused by a novel pathogen (NP), drug repurposing offers the potential…

Certara2021 年 2 月 9 日

White Paper

Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines

Certara2021 年 2 月 3 日

On-Demand Webinar

How drug developers can avoid these common mistakes to secure a deal

Emerging biotech companies sometimes lack all of the experience, expertise, or financial capital to successfully…

Certara2021 年 1 月 21 日

On-Demand Webinar

Making your biotech program investor-ready

Emerging biotech companies sometimes lack all of the experience, expertise, or financial capital to successfully…

Certara2021 年 1 月 21 日

On-Demand Webinar

新兴生物技术公司资产评估简介

Emerging biotech companies sometimes lack all of the experience, expertise, or financial capital to successfully…

Certara2021 年 1 月 21 日

Blog

Be honest, be reliable, be human: Insights from a global drug development expert

One of the most exciting things about working in the pharmaceutical industry is the ability…

Certara2020 年 12 月 16 日

Press Release

Certara Opens New China Office in Shanghai

Office will support rapid growth and collaboration with customers in China to accelerate biopharmaceutical R&D …

Certara2020 年 11 月 9 日

Blog

Using model-based meta-analysis to inform neuropathic pain drug development

Model-based Meta-analysis is a framework to compare drugs used to treat diabetic peripheral neuropathy, post-herpetic…

Certara2019 年 12 月 19 日

Poster

THE RELATIONSHIP BETWEEN mRNA AND ACTIVITY FOLLOWING INDUCTION OF CYP3A4 AND CYP2B6 ACROSS A RANGE OF PROTOTYPICAL INDUCERS

Certara2019 年 8 月 28 日

模型引导的药物开发

Sealing Pharma Commercialization Deals：为投资者创造最佳价值

BPS Article: 模型引导的药物再利用：新型病原体准备、反应和回顾的定量药理学方法

Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines

How drug developers can avoid these common mistakes to secure a deal

Making your biotech program investor-ready

新兴生物技术公司资产评估简介

Be honest, be reliable, be human: Insights from a global drug development expert

Certara Opens New China Office in Shanghai

Using model-based meta-analysis to inform neuropathic pain drug development

THE RELATIONSHIP BETWEEN mRNA AND ACTIVITY FOLLOWING INDUCTION OF CYP3A4 AND CYP2B6 ACROSS A RANGE OF PROTOTYPICAL INDUCERS

订阅时事通讯

快捷链接

解决方案

联系我们